Products

FerriSmart Analysis System
Resonance Health Analysis Services Pty
Gastroenterology AI
FerriSmart Analysis System is an AI-driven, FDA-cleared software that provides automated, real-time quantification of liver iron concentration from MRI images, aiding in the diagnosis and management of iron overload conditions.
LiverSmart
Resonance Health Analysis Services Pty
Gastroenterology AI
LiverSmart is an AI-powered MRI-based solution from Resonance Health that combines liver iron concentration (FerriSmart) and liver fat assessment (HepaFatSmart) into a single, comprehensive report for clinicians.
HepaFat-AI
Resonance Health Analysis Services Pty
Endocrinology & Metabolic AI
AI-driven software that automatically analyzes MRI datasets to assess liver fat in patients, providing a comprehensive multi-metric solution for fatty liver disease assessment.

See all 4 products →

About Resonance Health Analysis Services

Resonance Health is an Australian MedTech company specializing in the development and delivery of non-invasive medical imaging software and services. They provide advanced imaging solutions to assist clinicians and radiologists in the diagnosis and management of human diseases, particularly those related to iron overload and hepatic steatosis. Their comprehensive portfolio includes post-MRI analysis products and AI-powered solutions, designed to enhance decision-making, tailor patient care, and achieve superior outcomes.

Key offerings include FerriScan®, a highly precise R2-MRI technology for evaluating Liver Iron Concentration (LIC), crucial for managing conditions such as Thalassaemia. They also offer Cardiac T2* for heart iron assessment and HepaFatScan® for volumetric liver fat estimation. The company has expanded its AI-powered product line with FerriSmart® for automated LIC evaluation, HepaFatSmart® for multi-metric liver fat assessment, and LiverSmart®, which combines these into a single report. These Software as a Medical Device (SaMD) products hold regulatory clearances from the FDA, CE mark, and ARTG.

In addition to diagnostic tools, Resonance Health provides extensive clinical trial services to pharmaceutical and biotechnology companies, offering standardized analysis across multiple trial sites. Through its Resonance Clinical division, it acts as a Contract Research Organization (CRO), and with the acquisition of TrialsWest in 2024, it also offers investigator site services. The company’s focus areas include metabolic diseases (e.g., NAFLD, NASH), liver-related diseases (e.g., viral hepatitis), and iron overload disorders (e.g., hemochromatosis, thalassemia).

Focus Areas

Non-invasive medical imaging analysis Liver Iron Concentration (LIC) Liver Fat Assessment Liver Fibrosis Clinical Trial Services AI-powered diagnostics Software as a Medical Device (SaMD) Cardiac Iron Assessment

Business Intelligence

PartnershipsTrialsWest Pty Ltd (acquisition), CARPL.ai Inc., Micron Inc., Accumen's 3DR Labs, Alliance Medical Limited
AcquisitionsTrialsWest Pty Ltd (2024)
TechnologyMRI-based diagnostics software, AI-powered (machine learning, convolutional neural networks), Software as a Medical Device (SaMD), cloud-based platform (FAST portal)
FDA Clearances6 cleared products (estimated)

What Physicians Need to Know

Non-invasive Medical Imaging Analysis
Resonance Health specializes in non-invasive medical imaging analysis, primarily utilizing MRI technology to assess liver and heart conditions. This approach eliminates the need for invasive procedures like liver biopsies, enhancing patient comfort and safety.
Liver Iron Concentration (LIC) Assessment
They offer FerriScanu00ae, the internationally recognized 'gold standard' for quantifying liver iron concentration, and FerriSmartu00ae, an AI-powered automated solution for real-time LIC evaluation. These tools are crucial for managing conditions like thalassemia and hereditary hemochromatosis.
Liver Fat Assessment
HepaFatSmartu00ae and HepaFatScanu00ae provide automated, multi-metric assessments of liver fat, including volumetric liver fat fraction (VLFF), proton density fat fraction (PDFF), and steatosis grade. HepaFatSmartu00ae is an AI-powered solution, offering comprehensive reports.
Liver Fibrosis Assessment
Resonance Health is actively developing an MRI-based non-invasive biomarker for quantifying liver fibrosis and inflammation, with promising proof-of-concept studies underway. This aims to provide an accurate alternative to liver biopsy for disease staging and management.
Cardiac Iron Assessment
Their Cardiac T2* technology is the most widely accepted MRI-based method for assessing heart iron concentration, providing vital information for managing iron chelation therapy and assessing the risk of cardiac failure.
AI-Powered Diagnostics & SaMD
A core specialization is the development and commercialization of AI-powered Software as a Medical Device (SaMD) solutions like FerriSmartu00ae, HepaFatSmartu00ae, and LiverSmartu00ae. These utilize convolutional neural networks for automated, real-time analysis of medical images, minimizing human error and providing rapid results.
Clinical Trial Services
Resonance Health offers comprehensive clinical trial services to pharmaceutical companies and CROs, providing standardized, regulatory-cleared post-imaging software for multi-site analysis. Their services are MRI-agnostic, ensuring consistent data across various scanner types.
Physician Tip

For physicians, Resonance Health Analysis Services stands out due to its commitment to non-invasive, highly accurate, and reproducible MRI-based diagnostics. The AI-powered solutions like FerriSmartu00ae and HepaFatSmartu00ae deliver real-time or rapid results, enabling quicker clinical decision-making and tailored patient care. The 'gold standard' status of FerriScanu00ae for liver iron concentration provides high confidence in diagnoses. Their MRI-agnostic technology means that existing MRI equipment can be utilized without additional capital expenditure, streamlining workflows. Furthermore, the comprehensive multi-metric reports for liver iron and fat, along with ongoing development in liver fibrosis assessment, offer a holistic view of patient health, crucial for monitoring disease progression and treatment efficacy. The regulatory clearances (FDA, CE mark, TGA) ensure the reliability and safety of their SaMD products.

Resonance Health's services are designed for seamless integration into existing clinical workflows. DICOM files from MRI scans are securely transmitted via their proprietary FAST portal to their Core Lab for analysis. The results, often generated in real-time for AI-powered products or within two business days for others, are then securely transmitted back to the physician via the same portal. Their MRI-agnostic approach ensures compatibility with a wide range of MRI scanners from different vendors, requiring no specialized equipment purchases by radiology facilities.

Products by Resonance Health Analysis Services

4 products in the directory

FerriSmart Analysis System
Resonance Health Analysis Services Pty
Gastroenterology AI
FerriSmart Analysis System is an AI-driven, FDA-cleared software that provides automated, real-time quantification of liver iron concentration from MRI images, aiding in the diagnosis and management of iron overload conditions.
LiverSmart
Resonance Health Analysis Services Pty
Gastroenterology AI
LiverSmart is an AI-powered MRI-based solution from Resonance Health that combines liver iron concentration (FerriSmart) and liver fat assessment (HepaFatSmart) into a single, comprehensive report for clinicians.
HepaFat-AI
Resonance Health Analysis Services Pty
Endocrinology & Metabolic AI
AI-driven software that automatically analyzes MRI datasets to assess liver fat in patients, providing a comprehensive multi-metric solution for fatty liver disease assessment.
HepaFatSmart
Resonance Health Analysis Services Pty
Endocrinology & Metabolic AI
HepaFatSmart is an FDA-cleared, AI-powered Software-as-a-Medical Device (SaMD) that provides automated, multi-metric assessment of liver fat from MRI scans, including VLFF, PDFF, and steatosis grade.

Reviews & Opinions

No web reviews on file yet for Resonance Health Analysis Services. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Resonance Health Analysis Services.

Loading videos...

Videos load interactively. If none appear, search YouTube for Resonance Health Analysis Services →

View all on YouTube

Press & Coverage

Western Australian Government
Local Capability Fund: Health and Medical Life Sciences Industry recipients announced - Western Australian Government
Resonance Health Analysis Services Pty Ltd was among seven WA-based health and medical life sciences companies to receive a grant of $20,000 in June 2023 from the Local Capability Fund. This funding supports businesses in advancing their technology through national and international standard accreditation, specifically ISO 9001 and ISO 13485:2016.
2023-06
American Society of Hematology
Diagnostic Accuracy of a Fully Automated Method of Analysing MR Images for Evaluation of Liver Iron Concentration in a Population of Thalassemia Major Patients Following Curative Stem Cell Transplantation in Lebanon | Blood | American Society of Hematology
A study published in November 2023 in 'Blood' assessed the diagnostic accuracy of a new deep-learning trained neural network software system, DLA R2-MRI (FerriSmartu00ae, Resonance Health Analysis Services Pty Ltd), for analyzing MR images to evaluate liver iron concentration in thalassemia major patients. The software aims to increase the widespread adoption of reliable MRI-based LIC measurement.
2023-11
PMC (PubMed Central)
From research to reality: The role of artificial intelligence applications in HCC care - PMC
An article from April 2024 highlights Resonance Health Analysis Services' HepaFatSmart, an AI-driven solution for quantifying liver fat using MRI data, and FerriSmart, which utilizes AI to measure liver iron concentration. Their LiverSmart device integrates both fat and iron quantification technologies, aiding in the identification of patients at risk for HCC.
2024-04
Listcorp (ASX:RHT)
Appendix 4E & Full Year Statutory Accounts - Resonance Health Limited (ASX:RHT)
Resonance Health Limited, the parent company of Resonance Health Analysis Services Pty Ltd, reported in August 2025 a 29% increase in group revenue, reaching $11.07 million for FY2025, driven by strong demand in diagnostics and clinical trials. The company is also progressing its MRI Liver Fibrosis Project, a non-invasive MRI analysis for liver fibrosis.
2025-08
Therapeutic Goods Administration (TGA)
Resonance Health Analysis Services Pty Ltd - MRI system, application program software (520865) | Therapeutic Goods Administration (TGA)
The Therapeutic Goods Administration (TGA) in Australia lists Resonance Health Analysis Services Pty Ltd with an entry for 'MRI system, application program software' (ARTG ID 520865), with an effective date of November 26, 2025. This indicates regulatory clearance for their MRI software as a medical device.
2025-11
Therapeutic Goods Administration (TGA)
Resonance Health Analysis Services Pty Ltd | Therapeutic Goods Administration (TGA)
The TGA provides a sponsor information page for Resonance Health Analysis Services Pty Ltd, detailing various regulatory activities and listings for their MRI system application program software and diagnostic imaging phantoms, with several entries updated in 2024, 2025, and 2026.
2026
Government of Western Australia
AusBiotech 2024: Resonance Health - Government of Western Australia
In October 2024, the Government of Western Australia announced Resonance Health's participation in AusBiotech 2024, highlighting Resonance Health Analysis Services' provision of imaging CRO services for global clinical trials using their regulatory-cleared MRI Software as a Medical Device (SaMD) products.
2024-10
PhilPapers
Data over dialogue: Why artificial intelligence is unlikely to humanise medicine
A preprint from May 2026 discusses the FDA approval of Resonance Health Analysis Services' ML system in 2018 for automatically detecting abnormalities in patients' liver iron concentration levels, noting it as an example of medical ML systems.
2026-05

Frequently Asked Questions

Resonance Health provides a suite of non-invasive MRI-based analysis services, including FerriScan and FerriSmart for Liver Iron Concentration (LIC), HepaFatScan and HepaFatSmart for Liver Fat Assessment, and Cardiac T2* for Cardiac Iron Assessment. These services are designed to assist clinicians in diagnosing and managing patients with iron overload and fatty liver conditions.
Resonance Health integrates AI into several of its diagnostic products, such as FerriSmart for automated Liver Iron Concentration (LIC) quantification and HepaFatSmart for multi-metric liver fat assessment. These AI-powered solutions analyze MRI images to provide rapid, accurate, and reproducible results, enhancing diagnostic efficiency and supporting timely treatment decisions.
Yes, Resonance Health's SaMD products, including FerriScan, FerriSmart, HepaFatScan, HepaFatSmart, and LiverSmart, hold significant regulatory clearances. These include FDA (USA), CE mark (EU MDR 2017/745), and ARTG (Australia), demonstrating their adherence to international medical device standards.
Resonance Health offers comprehensive imaging CRO services for global clinical trials, utilizing its regulatory-cleared MRI SaMD products for standardized analysis across multiple sites. Their services include detailed proposals, dedicated project management, site setup, imaging charter development, and secure, timely clinical reports, all compliant with GCP and ISO 13485 standards.
Resonance Health is actively engaged in research and development for a non-invasive MRI-based biomarker to quantify liver fibrosis and inflammation. They have conducted promising proof-of-concept studies and are working towards regulatory clearances for broader market release, with early commercialization as an investigational use device for clinical trials.
Resonance Health ensures quality through ISO 13485 certification and rigorous quality checks performed by skilled physicists in their core lab for certain services. For support, they provide dedicated email contacts for general inquiries, customer support, and clinical trial inquiries, aiming for timely results and assistance.
Resonance Health has established strategic partnerships to expand its global footprint. Notably, they have an agreement with CARPL.ai Inc. to deliver their FerriSmart and HepaFat-AI SaMDs through CARPL.ai's global installations, and a collaboration with Micron Inc. to target the Japanese biopharmaceuticals market.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.